Charter Medical Launches New Biotech Processing Culture Bag
April 12, 2010 (FinancialWire) — Charter Medical, Ltd., a division of Lydall, Inc., (NYSE: LDL) has launched Bio-Pak Cell Culture bags for biotech and pharmaceutical processing.
The culture bags provide a stable cell culture environment to enhance cell growth and viability. They are made from Charter's high performance Clear-Pak film, a single web, multi-layer film with superior gas barrier properties. The Bio-Pak Cell Culture bags are offered in several sizes and configurations which can be customized to meet manufacturers' needs. This line will be produced on new equipment in Charter's recently expanded ISO Class 7 Clean Room.
Lydall, Inc. is headquartered in Manchester, Connecticut, with operations in the U.S., The Netherlands, France, and Germany, and sales offices in Europe and Asia.
FinancialWire(tm) is committed to serving the financial community through true journalism and providing relevant resources to investors. Standards-based, independent equity research on numerous public companies is available through the Investrend Research Syndicate (http://www.investrend.com/reports) written by FIRST Research Consortium (http://www.investrend.com/FIRST) member-providers. Free annual reports and company filings for companies mentioned in the news are available through the Investrend Information Syndicate (at http://investrend.ar.wilink.com/?level=279). FinancialWire(tm), in cooperation with the Investrend Broadcast Syndicate, also provides complete, daily conference call and webcast schedules as a service to shareholders and investors via the FirstAlert(tm) Network’s “FirstAlert(tm) Daily” (http://www.financialwire.net/news-alerts/).
FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) website (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.
[frlylrf] [biomedphrm] [erpnpre]
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.